Polyethylene glycol modified interferon therapy
US5908621A · kind A · utility
137Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 1997 |
| Grant date | Jun 1, 1999 |
| Priority date | — |
| Expiry date | Apr 29, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.